Showing results (301-310 of 316) with videos related to

Sort By:
Pageof 32
Gynecologic Oncology|November 29, 2011
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancerD Cibula, N R Abu-Rustum, L Dusek, et al.
JAMA Network Open|March 31, 2022
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate CancerRyon P Graf, Virginia Fisher, Janick Weberpals, et al.
The Journal of Molecular Diagnostics : JMD|July 25, 2025
Technical Advance, FoundationOne CDx and FoundationOne Heme Detect Epstein-Barr Virus with High Sensitivity and SpecificityJulius Honecker, Dirk Paffenholz, Julian Jungmann, et al.
ESMO Open|September 10, 2024
Durable benefit from poly(ADP-ribose) polymerase inhibitors in metastatic prostate cancer in routine practice: biomarker associations and implications for optimal clinical next-generation sequencing testingD Triner, R P Graf, R W Madison, et al.
Archives of Physical Medicine and Rehabilitation|August 2, 2020
Post-traumatic Confusional State: A Case Definition and Diagnostic CriteriaMark Sherer, Douglas I Katz, Yelena G Bodien, et al.
Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.
Journal of Neurotrauma|November 26, 2025
Development of a Structured Interview for the American Congress of Rehabilitation Medicine Diagnostic Criteria for Mild Traumatic Brain InjuryRael T Lange, Kelly C Gillow, , et al.
Cancer|August 11, 2021
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancerAndrea Necchi, Vito Cucchiara, Petros Grivas, et al.
The Oncologist|June 9, 2021
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain MetastasesRichard S P Huang, James Haberberger, Kimberly McGregor, et al.
NPJ Precision Oncology|September 14, 2024
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to PembrolizumabDouglas I Lin, Julia C F Quintanilha, Natalie Danziger, et al.
Pageof 32